Dr. Singh was appointed President and Chief Operating Officer in January 2019, after serving as President of our Diagnostics business since May 2014 and an officer of PerkinElmer since September 2016.
Prior to joining PerkinElmer, Dr. Singh was General Manager of GE Healthcare’s Women’s Health Business. In this role he had worldwide responsibility for GE Healthcare’s Mammography and Bone Densitometry businesses. Before that, Dr. Singh held senior executive level roles in Strategy, Business Development and M&A at both GE and Philips Healthcare. From 1995 to 2007, he held leadership roles of increasing responsibility at DuPont Pharmaceuticals and subsequently Bristol Myers Squibb Medical Imaging which included managing the Asia Pacific and Middle East region.
Dr. Singh holds a doctoral degree in Chemistry from the University of Missouri-Columbia and an M.B.A. from Northeastern University. His research work has resulted in several issued patents and publications in peer reviewed journals.